USANA Health Sciences, Inc. announced the financial results for the first fiscal quarter of 2025. Net sales within the quarter represented a 10% year-over-year growth rate, totaling $250 million versus $228 million in the first quarter of 2024. Net earnings, however, showed a decline from $16.5 million in Q1 2024 to $9.4 million. Adjusted EBITDA was $30 million, down from $33 million in Q1 2024, and adjusted diluted EPS was $0.73, compared to $0.86 in the same period last year.
Total active customers in the quarter totaled 459,000, down from 494,000 in the first quarter of 2024. Hiya active monthly subscribers reached 224,000, which the company described as strong momentum that “should continue building as their team executes their plans to launch several new products this year, unveil another strategic partnership, and expand to additional channels.” The company remains confident in Hiya’s growth trajectory and its ability to reach a new customer demographic.
“USANA is off to a solid start to the year as we continue to execute our growth strategy through our core direct sales business and our recently acquired direct-to-consumer business, Hiya,” said Jim Brown, USANA President and Chief Executive Officer. “We are seeing encouraging signs in our direct sales business with net sales and active customers growing modestly on a sequential basis for the second consecutive quarter. While the global macroeconomic environment has become less certain since the beginning of the year due to volatility in international trade, tariffs, and consumer sentiment, the underlying demand for our products has remained strong. Operationally, our manufacturing facilities in the United States and mainland China uniquely position us to deliver the best possible shopping experience and value to our customers in every market around the world. Our supply chain team has actively managed our inventory levels and sourcing, and will continue to work with our stakeholders in each of our markets to navigate the increasingly dynamic operating environment.”
The company generated $15 million in operating cash flow and ended the quarter with $180 million in cash and cash equivalents with $23 million in debt.
Fiscal outlook for the full-year 2025 remains unchanged, with consolidated net sales between $920 million to $1 billion.
